396092-83-4

Basic information

• Product Name: 2-Iodo-4-dimethylaminopyridine
• Synonyms: 2-Iodo-4-dimethylaminopyridine;2-iodo-N,N-dimethyl-4-Pyridinamine
• CAS NO: 396092-83-4
• Molecular Formula: C₇H₉IN₂
• Molecular Weight: 248.06
• Mol File: 396092-83-4.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 297.736°C at 760 mmHg
• Flash Point: 133.866°C
• Appearance: /
• Density: 1.738g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.642
• CAS DataBase Reference: 2-Iodo-4-dimethylaminopyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Iodo-4-dimethylaminopyridine(396092-83-4)
• EPA Substance Registry System: 2-Iodo-4-dimethylaminopyridine(396092-83-4)

Safety Data

• Hazardous Substances Data: 396092-83-4(Hazardous Substances Data)

Usage

Description

2-Iodo-4-dimethylaminopyridine is a chemical compound characterized by a pyridine ring with a dimethylamino group at the 4-position and an iodine atom at the 2-position. It is recognized for its versatility and effectiveness as a catalyst in organic synthesis, particularly in the formation of carbon-carbon and carbon-nitrogen bonds.

Uses

Used in Organic Synthesis:
2-Iodo-4-dimethylaminopyridine is used as a catalyst for promoting various organic reactions, including esterifications, amidations, and alkylations. Its ability to efficiently catalyze these reactions makes it a valuable tool in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical sector, 2-Iodo-4-dimethylaminopyridine is utilized for the synthesis of various active pharmaceutical ingredients. Its role in facilitating key chemical reactions contributes to the development of new and improved medications, thereby enhancing the scope of available treatments for various health conditions.

InChI:InChI=1/C7H9IN2/c1-10(2)6-3-4-9-7(8)5-6/h3-5H,1-2H3

Upstream product

• 1122-58-3 dmap 
• 83674-71-9 2,4-diiodo-pyridine 
• 124-40-3 dimethyl amine 
• 26452-80-2 2,4-dichloropyridine 

Downstream Products

• 918682-01-6 2-(3-methoxyphenyl)-4-dimethylaminopyridine 
• 37941-27-8 N,N-dimethyl-2-phenylpyridin-4-amine 
• 441072-26-0 2-(2,4-difluorophenyl)-4-N,N-dimethylaminopyridine 
• 918681-86-4 2-(3,5-difluorophenyl)-4-dimethylaminopyridine 
• 1017276-53-7 C₂₃H₂₈N₂O₅ 
• 1189463-00-0 2-(2,4-dichlorophenyl)-N,N-4-dimethylaminopyridin 
• 1416450-11-7 N²,N²'-((1R,2R)-cyclohexane-1,2-diyl)bis(N⁴,N⁴-dimethylpyridine-2,4-diamine) 
• 1421748-76-6 1-(3,5-bis(trifluoromethyl)phenyl)-3-((1R,2R)-2-((4-(dimethylamino)pyridin-2-yl)amino)cyclohexyl)thiourea 
• 1421748-66-4 C₁₄H₂₄N₄O₂S 
• 1421748-67-5 C₁₄H₂₁F₃N₄O₂S 
• 1421748-68-6 C₂₀H₂₈N₄O₂S 
• 1421748-69-7 C₂₂H₃₂N₄O₂S 
• 1421748-70-0 C₂₈H₄₄N₄O₂S 
• 1421748-71-1 C₂₂H₃₁N₅O₄S 

Relevant articles and documents

Design of an Os Complex-Modified Hydrogel with Optimized Redox Potential for Biosensors and Biofuel Cells

Multistep synthesis and electrochemical characterization of an Os complex-modified redox hydrogel exhibiting a redox potential ≈+30 mV (vs. Ag/AgCl 3 m KCl) is demonstrated. The careful selection of bipyridine-based ligands bearing N,N-dimethylamino moieties and an amino-linker for the covalent attachment to the polymer backbone ensures the formation of a stable redox polymer with an envisaged redox potential close to 0 V. Most importantly, the formation of an octahedral N6-coordination sphere around the Os central atoms provides improved stability concomitantly with the low formal potential, a low reorganization energy during the Os3+/2+ redox conversion and a negligible impact on oxygen reduction. By wiring a variety of enzymes such as pyrroloquinoline quinone (PQQ)-dependent glucose dehydrogenase, flavin adenine dinucleotide (FAD)-dependent glucose dehydrogenase and the FAD-dependent dehydrogenase domain of cellobiose dehydrogenase, low-potential glucose biosensors could be obtained with negligible co-oxidation of common interfering compounds such as uric acid or ascorbic acid. In combination with a bilirubin oxidase-based biocathode, enzymatic biofuel cells with open-circuit voltages of up to 0.54 V were obtained.

NOVEL COMPOUNDS

This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3 have meanings given in the description.

Light-Emitting Material

This invention pertains to light emitting materials comprising novel ortho-metalated transition metal complexes [C?N]2ML, comprising chelate monoionic ligands (L), also called ancillary ligands. It has been surprisingly found that when the ancillary ligand comprises a substituted aromatic ring bearing a substituent possessing adequate electron-donating properties, said ligand (L) advantageously participates in the emission process, significantly shifting emission towards higher energies (blue-shift) and enabling appreciable improvement of the emission efficiency of complexes [C?N]2ML. Still objects of the invention are the use of said light emitting materials and organic light emitting device comprising said light emitting material.